|
Match
|
Document |
Document Title |
|
|
US20120093936 |
METHOD AND DEVICE FOR TREATMENT OF CONDITIONS ASSOCIATED WITH INFLAMMATION OR UNDESIRABLE ACTIVATION OF THE IMMUNE SYSTEM
The present invention relates to methods and compositions for use in the treatment of specific medical conditions. The compositions of the invention comprise blood serum preparations, such as... |
|
|
US20150037430 |
FORMULATION OF A BLOOD COMPOSITION THAT IS RICH IN PLATELET AND/OR GROWTH FACTORS AND CONTAINS GELLED PROTEINS, AND A METHOD FOR ITS PREPARATION
Formulation comprising, or derived from, an initial blood composition, wherein the formulation is rich in platelets and/or growth factors and proteins originating from the initial blood... |
|
|
US20110177107 |
PREDICTING AND REDUCING ALLOIMMUNOGENICITY OF PROTEIN THERAPEUTICS
Methods of predicting the immunogenicity of a therapeutic protein in a subject are provided and the use of this method in selecting a protein for replacement therapy having the fewest immunogenic... |
|
|
US20140242044 |
Devices and methods for treating defects in the tissue of a living being
An implant for deployment in select locations or select tissue for regeneration of tissue is disclosed. The implant includes collagen and or other bio-resorbable materials, where the implant may... |
|
|
US20120195947 |
PROTEIN NANOCARRIERS FOR TOPICAL DELIVERY
The invention encompasses nanoparticle assemblies and methods for preparing nanoparticle and compositions comprising such nanoparticles for use in topical or skin applications. The invention... |
|
|
US20120165939 |
NONWOVEN TISSUE SCAFFOLD
A biocompatible meniscal repair device is disclosed. The tissue repair device includes a scaffold adapted to be placed in contact with a defect in a meniscus, the scaffold comprising a... |
|
|
US20110008458 |
Process for removing growth factors from platelets
A sub-atmospheric, negative pressure is applied to a growth factor starting material, such as whole blood, to release growth factors and plasma in a non-destructive medium. The released growth... |
|
|
US20150238528 |
Formulations Involving Solvent/Detergent-Treated Plasma (S/D Plasma) and Uses Thereof
The invention concerns pharmaceutical formulations comprising solvent/detergent (S/D)-treated plasma and a glycosaminoglycan such as hyaluronic acid, and their use for treating diseases,... |
|
|
US20150247847 |
DIAGNOSTIC METHOD FOR DETECTING AN AUTOIMMUNE DISEASE AND RELATED SUBJECT-MATTER
The present invention relates to a polypeptide or protein for use in a method of diagnosis or treatment of an autoimmune disease in a subject, characterized in that said polypeptide or protein... |
|
|
US20080166421 |
METHOD OF SURGICAL TREATMENT USING AUTOLOGOUS CONDITIONED PLASMA
A method of providing autologous conditioned plasma (ACP) for treatment of connective tissue injuries. The method comprises the steps of: (i) providing an apparatus comprising a centrifuge and a... |
|
|
US20120087988 |
METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY CONDITIONS USING PLATELET ENRICHED PLASMA
Described herein are methods and compositions for the treatment of respiratory diseases such as, for example, exercise induced pulmonary hemorrhage. The methods include the use of compositions... |
|
|
US20140271786 |
BIOACTIVE POROUS BONE GRAFT COMPOSITIONS IN SYNTHETIC CONTAINMENT
Bioactive porous bone graft implants in various forms suitable for use in bone tissue regeneration and/or repair, as well as methods of use are provided. The implants are formed of bioactive glass... |
|
|
US20150157664 |
METHODS AND COMPOSITIONS FOR TREATING AGING-ASSOCIATED CONDITIONS
Methods and compositions are provided for treating a subject for aging-associated conditions, e.g., cognitive impairment conditions. Aspects of the methods include administering a young... |
|
|
US20140083945 |
Reducing Soluble Urokinase Receptor in the Circulation
Focal segmental glomerulosclerosis (FSGS) is a common cause of proteinuric kidney disease, which comprises both native and transplanted kidneys. Treatment was limited in the past due to the... |
|
|
US20140161899 |
METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINS
The instant invention provides a method to reduce adverse events caused by a pharmaceutical preparation derived from a plasma fraction wherein the method comprises contacting the plasma fraction... |
|
|
US20140105997 |
GALECTIN-3 PLASMAPHERESIS THERAPY
The invention is directed to the removal of serum gal-3 from circulation by plasmapheresis, comprising at least in part donor apheresis, using gal-3 binding agents in either a fixed bed, or in a... |
|
|
US20140112890 |
INTRAOPERATIVE AND BLOOD DERIVED ADHESIVES
The invention features the production of an amine-reactive proteoglycan, specifically chondroitin sulfate or hyaluronic acid. This material can be provided in powder (solid) or liquid form and... |
|
|
US20150004245 |
Composition for Promoting Increase in Subcutaneous Tissue and Subcutaneous Adipose Tissue
In particular, a composition for breast augmentation that includes a composition promoting an increase in subcutaneous tissue, wherein the promoting composition aims at accumulating and increasing... |
|
|
US20130273017 |
METHODS AND PRODUCTS FOR TISSUE REPAIR
Methods and devices for the repair of articular tissue using collagen material are provided. Compositions of collagen material and related kits are also provided. |
|
|
US20150150911 |
METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINS
The instant invention provides a method to reduce adverse events caused by a pharmaceutical preparation derived from a plasma fraction said plasma fraction comprising antithrombin III wherein the... |
|
|
US20150196596 |
COMPOSITIONS SUITABLE FOR TREATMENT OF SPINAL DISEASE, DISORDER OR CONDITION
The invention relates to the use of viral inactivated-plasma cryoprecipitate concentrate (VIPCC) comprising a suitable fibronactin/fibrinogen ratio for treating a spine disease, disorder or... |
|
|
US20100310524 |
Compositions Suitable for Treatment of Spinal Disease, Disorder or Condition
The invention relates to the use of viral inactivated-plasma cryoprecipitate concentrate (VIPCC) comprising a suitable fibronectin/fibrinogen ratio for treating a spine disease, disorder or... |
|
|
US20110229499 |
METHOD FOR TREATMENT OF VASCULAR HYPERPERMEABILITY
A method for treating or preventing hemorrhagic shock comprising administering a composition comprising stem cells or a soluble factor produced by stem cells, such as stem cell factor (SCF) to a... |
|
|
US20150064133 |
BIOACTIVE COMPOSITIONS DERIVABLE FROM PLATELET CONCENTRATES, AND METHODS FOR PREPARING AND USING SAME
The present disclosure provides a composition comprising a bioactive fraction derived from a platelet concentrate, methods of making the bioactive fraction, and culture medium supplemented with... |
|
|
US20110111049 |
Ischemia/reperfusion protection compositions and methods of using
The invention provides for ischemia/reperfusion protection compositions having one or more ketone bodies and melatonin. The invention also provides for methods of using such compositions to reduce... |
|
|
US20130243878 |
BIOMATERIALS FOR DELIVERY OF BLOOD EXTRACTS AND METHODS OF USING SAME
The disclosure provides biomaterials including scaffolds that include blood products including blood fractions and products including platelets for administration to subjects in need thereof. More... |
|
|
US20130216626 |
PLATELET-RICH PLASMA COMPOSITIONS
The present invention relates to a method of treating functional disability and/or pain associated with joints, tendons or connective tissue diseases, disorders or injuries comprising oral... |
|
|
US20120315259 |
METHOD AND COMPOSITION FOR SKIN CARE COMPRISING CORD BLOOD SERUM OR PLASMA OR COMPONENTS THEREOF
A method and composition for treating dermatological conditions and improving skin condition and helping hair to grow or thicken involves removing extracts including beneficial secretions from... |
|
|
US20150247851 |
DIAGNOSIS AND TREATMENT OF AUTOANTIBODY-MEDIATED HEART DISEASE
Provided herein are, inter alia, methods of diagnosing and treating autoimmune cardiomyopathy in subjects, based upon the detection of IgG4 antibodies to cardiac autoantigens. |
|
|
US20080248081 |
METHOD OF TREATING CHRONIC DYSFUNCTION OF CARDIAC MUSCLE
Methods are described for using compositions containing platelet-rich plasma for the treatment of a variety of tissue lesions. Particularly, delivery of platelet-rich plasma to cardiac muscle for... |
|
|
US20130121979 |
METHOD OF TREATING CANCER USING PLATELET COMPOSITIONS
Platelets are concentrated from the blood of a patient. The platelets are unactivated or are treated by a method such as ultrasound or agitation to obtain platelet releasate. The platelets are... |
|
|
US20150192576 |
METHODS AND REAGENTS FOR PREVENTION AND/OR TREATMENT OF TRANSPLANT REJECTION
The present invention relates to methods for determining the probability of transplant rejection based on the determination in the subject recipient of the transplant of the levels of antibodies... |
|
|
US20120201897 |
COMPOSITION FOR INDUCING TISSUE REGENERATION BY ACTIVATING PLATELET-RICH PLASMA (PRP), AND METHOD FOR MANUFACTURING SAME
The present invention relates to a composition for cartilaginous tissue repair and to a production method therefor. The present invention comprises the steps of: (a) dissolving freeze-dried... |
|
|
US20120027867 |
Spray-Dried Blood Products and Methods of Making Same
The present invention is directed to a method of preparing dehydrated blood products, comprising the steps of: (a) providing a hydrated blood product; (b) spray-drying the hydrated blood product... |
|
|
US20120201896 |
BIOLOGIC REPLACEMENT FOR FIBRIN CLOT
The invention provides composition and methods for repairing a ruptured anterior cruciate ligament. |
|
|
US20140099293 |
METHOD FOR EX-VIVO SEPARATION OF APOPTOTIC CHROMATIN FRAGMENTS FROM BLOOD OR PLASMA FOR PREVENTION AND TREATMENT OF DIVERSE HUMAN DISEASES
A method of prevention/treatment of pathological consequences of DNA damage triggered by incorporation of circulating apoptotic chromatin fragments into healthy cells of individuals/patients in... |
|
|
US20140234432 |
ENHANCING COAGULATION OR REDUCING FIBRINOLYSIS
Methods for controlling bleeding (e.g., enhancing coagulation and reducing fibrinolysis) in a subject are disclosed. The methods include selecting a subject in need of enhanced coagulation or... |
|
|
US20140242181 |
PREPARATION OF FIBRIN GEL FOR USE AS IMPLANT SYSTEM
The present invention aims to generate a fibrin gel for cell proliferation and transport using the patient's own blood or compatible blood. The gel-preparation process consists in taking a... |
|
|
US20120045518 |
ENHANCING COAGULATION OR REDUCING FIBRINOLYSIS
Methods for controlling bleeding (e.g., enhancing coagulation and reducing fibrinolysis) in a subject are disclosed. The methods include selecting a subject in need of enhanced coagulation or... |
|
|
US20150086536 |
Methods of Predicting Acute Rejection Outcomes
A method for assessing risk of losing a transplanted organ by a patient having an episode of acute rejection of the transplanted organ is described. The method includes obtaining from the patient... |
|
|
US20120251609 |
DEMINERALIZED CANCELLOUS BONE MATRIX
A demineralized cancellous bone matrix comprising a cancellous bone matrix that has been demineralized is described herein. The demineralized cancellous bone matrix is rigid and has certain... |
|
|
US20120114760 |
COMPOSITIONS FOR TREATING WOUNDS AND PROCESSES FOR THEIR PREPARATION
Embodiments of the invention are directed to methods of treating a wound by administering a wound-healing composition and the wound-healing composition. The wound-healing composition has a... |
|
|
US20130177623 |
Preparation Rich in Growth Factor-Based Fibrous Matrices for Tissue Engeering, Growth Factor Delivery, and Wound Healling
Activated platelet-rich plasma (aPRP) is electrospun into fibrous matrices which are used to deliver components of aPRP to a site of action in a sustained manner. The electrospun matrices are... |
|
|
US20150147300 |
Methods Of Mediating Macrophage Phenotypes
Methods of inducing a polarization of macrophages. The method includes obtaining a blood fraction, fractionating the blood fraction to produce a blood fraction, and contacting the blood fraction... |
|
|
US20110280952 |
Platelet Lysate and Bioadhesive Compositions Thereof for the Treatment of Mucositis
The present invention concerns the use of platelet lysate for treating and/or preventing mucositis. Moreover, a mucoadhesive composition comprising such a platelet lysate for the therapy and/or... |
|
|
US20140186455 |
Tissue repair system
An implant for promoting accelerated wound healing. The implant comprises a non-flocculating fiber material, admixed with a settable fluid. The fiber component typically will have short fiber... |
|
|
US20080248084 |
METHOD OF TREATING ACUTE DYSFUNCTION OF CARDIAC MUSCLE
Methods are described for using compositions containing platelet-rich plasma for the treatment of a variety of tissue lesions. Particularly, delivery of platelet-rich plasma to treat acute... |
|
|
US20130243879 |
PLATELET RICH PLASMA FORMULATIONS AND USE THEREOF
Compositions for platelet rich plasma (PRP), depleted in neutrophils, are provided. Generally, these compositions comprise a higher concentration of platelets, lymphocytes and monocytes than whole... |
|
|
US20140044797 |
PROSTACYCLIN AND ANALOGS THEREOF ADMINISTERED DURING SURGERY FOR PREVENTION AND TREATMENT OF CAPILLARY LEAKAGE
The present invention relates to the novel use of prostacyclin analogs for prevention and/or treatment of capillary leakage during surgery. The treatment of the present invention mediates discrete... |
|
|
US20080292597 |
Umbilical Cord Stem Cell Composition & Method of Treating Neurological Diseases
A neurological disease is treated by administering to a patient a therapeutically effective amount of a composition including human umbilical cord stem cells. The composition may include growth... |